687 related articles for article (PubMed ID: 22150126)
1. Sublingual allergen immunotherapy: mode of action and its relationship with the safety profile.
Calderón MA; Simons FE; Malling HJ; Lockey RF; Moingeon P; Demoly P
Allergy; 2012 Mar; 67(3):302-11. PubMed ID: 22150126
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of subcutaneous and sublingual immunotherapy with grass allergens for seasonal allergic rhinitis: a meta-analysis-based comparison.
Di Bona D; Plaia A; Leto-Barone MS; La Piana S; Di Lorenzo G
J Allergy Clin Immunol; 2012 Nov; 130(5):1097-1107.e2. PubMed ID: 23021885
[TBL] [Abstract][Full Text] [Related]
3. Economic evaluation of sublingual vs subcutaneous allergen immunotherapy.
Pokladnikova J; Krcmova I; Vlcek J
Ann Allergy Asthma Immunol; 2008 May; 100(5):482-9. PubMed ID: 18517082
[TBL] [Abstract][Full Text] [Related]
4. [New administration routes for immunotherapy].
Martorell Aragonés A
Allergol Immunopathol (Madr); 2000; 28(3):93-102. PubMed ID: 10867377
[TBL] [Abstract][Full Text] [Related]
5. Ultra short pre-seasonal subcutaneous immunotherapy and pre-coseasonal sublingual immunotherapy for pollen allergy: an evaluation of patient's preference in real life.
Manzotti G; Pappacoda A; Dimatteo M; Scolari C; Riario-Sforza GG; Incorvaia C
Eur Ann Allergy Clin Immunol; 2013 Aug; 45(4):138-43. PubMed ID: 24067339
[TBL] [Abstract][Full Text] [Related]
6. Immune mechanisms of allergen-specific sublingual immunotherapy.
Moingeon P; Batard T; Fadel R; Frati F; Sieber J; Van Overtvelt L
Allergy; 2006 Feb; 61(2):151-65. PubMed ID: 16409190
[TBL] [Abstract][Full Text] [Related]
7. Update on immune mechanisms associated with sublingual immunotherapy: practical implications for the clinician.
Moingeon P
J Allergy Clin Immunol Pract; 2013; 1(3):228-41. PubMed ID: 24565479
[TBL] [Abstract][Full Text] [Related]
8. A novel approach in allergen-specific immunotherapy: combination of sublingual and subcutaneous routes.
Keles S; Karakoc-Aydiner E; Ozen A; Izgi AG; Tevetoglu A; Akkoc T; Bahceciler NN; Barlan I
J Allergy Clin Immunol; 2011 Oct; 128(4):808-815.e7. PubMed ID: 21641635
[TBL] [Abstract][Full Text] [Related]
9. Subcutaneous versus sublingual immunotherapy for allergic rhinitis and/or asthma.
Bahceciler NN; Cobanoglu N
Immunotherapy; 2011 Jun; 3(6):747-56. PubMed ID: 21668312
[TBL] [Abstract][Full Text] [Related]
10. Systemic tolerability of specific subcutaneous immunotherapy with index-of-reactivity-standardized allergen extracts administered using clustered regimens: a retrospective, observational, multicenter study.
Serrano P; Justicia JL; Sánchez C; Cimarra M; Fernández-Távora L; Orovitg A; Moreno C; Guerra F; Alvà V
Ann Allergy Asthma Immunol; 2009 Mar; 102(3):247-52. PubMed ID: 19354072
[TBL] [Abstract][Full Text] [Related]
11. Dose dependence of efficacy but not of safety in sublingual immunotherapy.
Frati F; Incorvaia C; Marcucci F; Sensi L; Di Cara G; Puccinelli P; Dal Bo S
Monaldi Arch Chest Dis; 2006 Mar; 65(1):38-40. PubMed ID: 16700192
[TBL] [Abstract][Full Text] [Related]
12. One century of allergen-specific immunotherapy for respiratory allergy.
Incorvaia C; Frati F
Immunotherapy; 2011 May; 3(5):629-35. PubMed ID: 21554092
[TBL] [Abstract][Full Text] [Related]
13. Sublingual immunotherapy in children modulates allergen-induced in vitro expression of cytokine mRNA in PBMC.
Savolainen J; Jacobsen L; Valovirta E
Allergy; 2006 Oct; 61(10):1184-90. PubMed ID: 16942566
[TBL] [Abstract][Full Text] [Related]
14. Sublingual immunotherapy for Japanese cedar pollinosis.
Okubo K; Gotoh M
Allergol Int; 2009 Jun; 58(2):149-54. PubMed ID: 19390236
[TBL] [Abstract][Full Text] [Related]
15. Effect of sublingual immunotherapy with grass monomeric allergoid on allergen-specific T-cell proliferation and interleukin 10 production.
Burastero SE; Mistrello G; Falagiani P; Paolucci C; Breda D; Roncarolo D; Zanotta S; Monasterolo G; Rossi RE
Ann Allergy Asthma Immunol; 2008 Apr; 100(4):343-50. PubMed ID: 18450120
[TBL] [Abstract][Full Text] [Related]
16. Dosing and efficacy in specific immunotherapy.
Demoly P; Calderon MA
Allergy; 2011 Jul; 66 Suppl 95():38-40. PubMed ID: 21668851
[TBL] [Abstract][Full Text] [Related]
17. Immunological mechanisms of sublingual allergen-specific immunotherapy.
Novak N; Bieber T; Allam JP
Allergy; 2011 Jun; 66(6):733-9. PubMed ID: 21251016
[TBL] [Abstract][Full Text] [Related]
18. Sublingual-oral administration of standardized allergenic extracts: phase 1 safety and dosing results.
Esch RE; Bush RK; Peden D; Lockey RF
Ann Allergy Asthma Immunol; 2008 May; 100(5):475-81. PubMed ID: 18517081
[TBL] [Abstract][Full Text] [Related]
19. Safety of sublingual grass pollen immunotherapy after anaphylaxis.
Nichani JR; de Carpentier J
J Laryngol Otol; 2009 Jun; 123(6):683-4. PubMed ID: 18501039
[TBL] [Abstract][Full Text] [Related]
20. Detection of risk factors for systemic adverse reactions to SCIT with natural depot allergen extracts: a retrospective study.
Asero R
Eur Ann Allergy Clin Immunol; 2015 Nov; 47(6):211-7. PubMed ID: 26549339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]